Time to deterioration of symptoms with durvalumab in stage III, locally advanced, unresectable NSCLC: Post-hoc analysis of PACIFIC patient-reported outcomes

Hui, R.Ozguroglu, M.Villegas, A.Daniel, D.Vicente, D.Murakami, S.Ryden, A.Zhang, Y.Dennis, P.Antonia, S.2025-01-072025-01-072018-04-011556-0864https://hdl.handle.net/10668/27571enTime to deterioration of symptoms with durvalumab in stage III, locally advanced, unresectable NSCLC: Post-hoc analysis of PACIFIC patient-reported outcomesconference outputopen access10.1016/S1556-0864(18)30401-51556-1380http://www.jto.org/article/S1556086418304015/pdf436557600122